These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20146479)

  • 1. Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
    Siddiqui MA; Reddy PA
    J Med Chem; 2010 Apr; 53(8):3005-12. PubMed ID: 20146479
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of c-Jun N-terminal kinases: an update.
    Koch P; Gehringer M; Laufer SA
    J Med Chem; 2015 Jan; 58(1):72-95. PubMed ID: 25415535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK: bridging the insulin signaling and inflammatory pathway.
    Liu G; Rondinone CM
    Curr Opin Investig Drugs; 2005 Oct; 6(10):979-87. PubMed ID: 16259218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
    J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps.
    Kodama Y; Brenner DA
    Hepatology; 2009 Jan; 49(1):6-8. PubMed ID: 19111006
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
    Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
    Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
    Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.
    Arnold DM; Foster C; Huryn DM; Lazo JS; Johnston PA; Wipf P
    Chem Biol Drug Des; 2007 Jan; 69(1):23-30. PubMed ID: 17313454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic promise of JNK ATP-noncompetitive inhibitors.
    Bogoyevitch MA
    Trends Mol Med; 2005 May; 11(5):232-9. PubMed ID: 15882611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
    Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
    Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm.
    Yoshimura K; Aoki H; Ikeda Y; Furutani A; Hamano K; Matsuzaki M
    Ann N Y Acad Sci; 2006 Nov; 1085():403-6. PubMed ID: 17182964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
    Cho H; Black SC; Looper D; Shi M; Kelly-Sullivan D; Timofeevski S; Siegel K; Yu XH; McDonnell SR; Chen P; Yie J; Ogilvie KM; Fraser J; Briscoe CP
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1142-51. PubMed ID: 18728225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.
    Jiang R; Duckett D; Chen W; Habel J; Ling YY; LoGrasso P; Kamenecka TM
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6378-82. PubMed ID: 17911023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of c-jun-N-terminal kinase (JNK).
    LoGrasso P; Kamenecka T
    Mini Rev Med Chem; 2008 Jul; 8(8):755-66. PubMed ID: 18673131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
    Koh YH; Tamizhselvi R; Bhatia M
    J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain.
    Waetzig V; Herdegen T
    Neurosci Lett; 2004 May; 361(1-3):64-7. PubMed ID: 15135894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.